CD8A and neoplasm: Here, INCAGN01876 treatment was associated with T-cell activation, based on observed increases in HLA-DR on T cells, and a trend of decrease in GITR+ Treg, which coincided with a trend of increase in CD8+ Ki67+ T cells both in peripheral blood and tumor samples from a subset of patients.